In a meta-analysis which included 15 studies of approximately 10,995 participants who were treated with orlistat or placebo for at least 6 to 12 months, treatment with orlistat was associated with a significant decrease in total cholesterol after adjustment for weight loss [29], which indicates orlistat is a useful adjunctive tool for improving cardiovascular risk factor profiles in obese patients
However, affiliate relationships do not influence the content, product reviews, or editorial recommendations provided
It has been specially developed to enhance its effectiveness by providing nutritional support through a unique blend of Vitamin C from several sources, along with proven antioxidants, herbs, and vitamins commonly used for benefit
Three types of nutrients most reliably trigger them: protein, healthy fats, and fiber
Additional studies of GLP-1s efficacy in cardiovascular indications are underway